Pharmacists’ perspectives on methamphetamine use disorder in the Australian community setting
DOI:
https://doi.org/10.46542/pe.2024.241.772781Keywords:
Community pharmacy, Methamphetamine use disorder, Pharmacist, Qualitative study, Substance use disorderAbstract
Background: Methamphetamine Use Disorder (MUD) poses significant harm to individuals and communities. In Australia, pharmacies have been involved in harm reduction services, primarily focusing on opioids. While much is known about pharmacists' attitudes toward opioid use disorder, there is limited understanding of their perspectives and management of MUD. This study aimed to explore pharmacists’ perspectives on the provision of services to clients with MUD.
Methods: Recruitment of pharmacists involved a snow-ball and convenience sampling strategy across Sydney, Australia. Semi-structured interviews were undertaken to explore pharmacists’ perspectives on the treatment and management of MUD in the pharmacy setting. Transcribed interviews were qualitatively analysed using an inductive approach, coding themes from the data emerging.
Results: Nineteen pharmacists completed the interviews. The strongest theme emerging from the transcripts described pharmacists’ reported unfamiliarity with MUD. Participating pharmacists almost unanimously perceived there was a lack of educational resources surrounding MUD, inadequate university curricular on MUD, and a lack of support for pharmacists’ role in any prospective MUD treatment programs.
Conclusion: Studies indicate that pharmacists are often unfamiliar with MUD, which, along with insufficient educational resources, causes low confidence and hinders their ability to support individuals with MUD. Implementing targeted educational interventions for pharmacists is essential to improve their effectiveness in MUD treatment programmes.
References
Australian Institute of Health & Welfare. (2024). Methamphetamine and amphetamine in the NDSHS. https://www.aihw.gov.au/reports/illicit-use-of-drugs/meth-amphetamine-ndshs
Chaar, B. B., Hanrahan, J. R., & Day, C. (2011). Provision of opioid substitution therapy services in Australian pharmacies. Australasian Medical Journal, 4(4), 210‒216. https://doi.org/10.4066/amj.2011.706
Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019). Pharmacotherapy for methamphetamine/amphetamine use disorder—A systematic review and meta-analysis. Addiction, 114(12), 2122‒2136. https://doi.org/https://doi.org/10.1111/add.14755
Comanici, K. H., Nichols, M. A., Scott, C., Conklin, M., Ott, C. A., Arnett, S., & Karwa, R. (2023). Understanding the role of community pharmacies in current medication for opioid use disorder care practices. Journal of the American Pharmacists Association, 63(1), 261‒268.e262. https://doi.org/https://doi.org/10.1016/j.japh.2022.08.027
Corbin, J., & Strauss, A. (2014). Basics of qualitative research: Techniques and procedures for developing grounded theory. SAGE Publications. https://books.google.com.au/books?id=hZ6kBQAAQBAJ
Countey, H., Steinbronn, C., & Grady, S. E. (2018). Changing student attitudes and perceptions toward opioid use disorder. Mental Health Clinician, 8(5), 222‒226. https://doi.org/10.9740%2Fmhc.2018.09.222
Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., Burns, L., & Hall, W. D. (2017). Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review, 36(2), 160‒170. https://doi.org/10.1111/dar.12426
DiPaula, B. A., Cooke, C. E., Boyle, C. J., & Love, R. C. (2022). Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction. Journal of the American Pharmacists Association, 62(1), 241‒246. https://doi.org/https://doi.org/10.1016/j.japh.2021.09.012
Driesen, A., Verbeke, K., Simoens, S., & Laekeman, G. (2007). International trends in lifelong learning for pharmacists. American Journal of Pharmaceuticals Education, 71(3), 52. https://doi.org/10.5688/aj710352
Eukel, H., Steig, J., Frenzel, O., Skoy, E., Werremeyer, A., & Strand, M. (2020). Opioid misuse and overdose: Changes in pharmacist practices and outcomes. Journal of Continuing Education in the Health Professions, 40(4), 242‒247. https://doi.org/10.1097/ceh.0000000000000317
Eukel, H. N., Skoy, E., Werremeyer, A., Burck, S., & Strand, M. (2019). Changes in pharmacists' perceptions after a training in opioid misuse and accidental overdose prevention. Journal of Continuing Education in the Health Professions, 39(1), 7‒12. https://doi.org/10.1097/ceh.0000000000000233
FIP. (2022). Competency-based education in pharmacy and pharmaceutical sciences, A FIP handbook to support implementation of competency-based education and training. The Hague, FIP, Version 1.
Hagemeier, N. E., Alamian, A., Murawski, M. M., & Pack, R. P. (2015). Factors associated with provision of addiction treatment information by community pharmacists. Journal of Substance Abuse Treatment, 52, 67‒72. https://doi.org/https://doi.org/10.1016/j.jsat.2014.11.006
Hattingh, H. L., & Tait, R. J. (2017). Pharmacy-based alcohol-misuse services: Current perspectives. Integrated Pharmacy Research and Practice, 7, 21‒31. https://doi.org/10.2147/iprp.S140431
Horsfield, E., Sheridan, J., & Anderson, C. (2011). What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. International Journal of Pharmacy Practice, 19(3), 192‒200. https://doi.org/10.1111/j.2042-7174.2011.00112.x
Katoue, M. G., & Schwinghammer, T. L. (2020). Competency-based education in pharmacy: A review of its development, applications, and challenges. Journal of Evaluation in Clinical Practice, 26(4), 1114‒1123. https://doi.org/https://doi.org/10.1111/jep.13362
Kheir, N., & Wilbur, K. (2018). Chapter 13 - Continuing professional development and self-learning for pharmacists. In A. I. Fathelrahman, M. I. Mohamed Ibrahim, A. A. Alrasheedy, & A. I. Wertheimer (Eds.), Pharmacy education in the twenty first century and beyond (pp. 191‒200). Academic Press. https://doi.org/https://doi.org/10.1016/B978-0-12-811909-9.00013-7
Loera, L. J., Hill, L. G., Zagorski, C. M., Jermain, M. L., & Tirado, C. F. (2023). Description and evaluation of a pilot advanced pharmacy practice experience in addiction medicine. American Journal of Pharmaceuticals Education, 87(1), ajpe8926. https://doi.org/10.5688/ajpe8926
Lukey, R., Gray, B., & Morris, C. (2020). 'We're just seen as people that give out the methadone…': Exploring the role of community pharmacists in the opioid substitution treatment team. Journal of Primary Health Care, 12(4), 358‒367. https://doi.org/10.1071/hc20108
Makki, A., Day, C., & Chaar, B. B. (2024). Professional stigma towards clients with methamphetamine use disorder–A qualitative study. Journal of Pharmaceutical Policy and Practice, 17(1), 2306869. https://doi.org/10.1080/20523211.2024.2306869
Man, N., Sisson, S. A., McKetin, R., Chrzanowska, A., Bruno, R., Dietze, P. M., Price, O., Degenhardt, L., Gibbs, D., Salom, C., & Peacock, A. (2022). Trends in methamphetamine use, markets and harms in Australia, 2003–2019. Drug and Alcohol Review, 41(5), 1041‒1052. https://doi.org/https://doi.org/10.1111/dar.13468
Matheson, C., Thiruvothiyur, M., Robertson, H., & Bond, C. (2016). Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development. International Journal of Drug Policy, 27, 105‒112. https://doi.org/https://doi.org/10.1016/j.drugpo.2015.11.006
McKetin, R., Kelly, E., & McLaren, J. (2006). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend, 85(3), 198‒204. https://doi.org/10.1016/j.drugalcdep.2006.04.007
McMillan, S. S., Chan, H., & Hattingh, L. H. (2021). Australian community pharmacy harm-minimisation services: Scope for service expansion to improve healthcare access. Pharmacy (Basel), 9(2). https://doi.org/10.3390/pharmacy9020095
Murnane, K. S., Augustine, J. M., & Marshall, L. L. (2022). Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of data. Currents in Pharmacy Teaching and Learning, 14(10), 1222‒1228. https://doi.org/https://doi.org/10.1016/j.cptl.2022.09.012
Musco, S., Kicklighter, J., & Arnett, A. (2022). Expanding naloxone education in the doctor of pharmacy curriculum. Currents in Pharmacy Teaching and Learning, 14(3), 310‒317. https://doi.org/https://doi.org/10.1016/j.cptl.2022.01.008
Muzyk, A., Smothers, Z. P. W., Collins, K., MacEachern, M., & Wu, L.-T. (2019). Pharmacists’ attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature. Substance Abuse, 40(4), 476‒483. https://doi.org/10.1080/08897077.2019.1616349
Nagy, G., Arató, F., Télessy, I. G., Varga, A., & Fittler, A. (2023). A scoping review of educator proficiency interventions in pharmacy education illustrated by an interdisciplinary model integrating pedagogical theories into practice. Pharmacy, 11(6), 172. https://www.mdpi.com/2226-4787/11/6/172
Nielsen, S., Menon, N., Larney, S., Farrell, M., & Degenhardt, L. (2016). Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. Addiction, 111(12), 2177‒2186. https://doi.org/https://doi.org/10.1111/add.13517
NVivo. (2020). NVivo. In QSR International Pty Ltd. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
Odusola, F., Kaufman, J., Turrigiano, E., Aydinoglo, N., Shulman, M., Kidd, J., Hu, M. C., & Levin, F. R. (2021). Predoctoral substance use disorders curricula: A survey analysis and experiential pedagogy. Journal of Dental Education, 85(10), 1664‒1673. https://doi.org/10.1002/jdd.12697
Otter.ai. (2023). Otter. https://otter.ai/
Richards, L. (2005). Handling Qualitative Data: A Practical Guide. SAGE Publications Ltd
Ritter, A., Chalmers, J., & Gomez, M. (2019). Measuring Unmet demand for alcohol and other drug treatment: The application of an Australian population-based planning model. Journal of Studies on Alcohol and Drugs, Supplemental 18, 42‒50. https://doi.org/10.15288/jsads.2019.s18.42
Rouse, M. J. J. J. o. P. T. (2004). Continuing professional development in pharmacy. 20(5), 303-306.
Sachidanandan, G., Bechard, L. E., Hodgson, K., & Sud, A. (2022). Education as drug policy: A realist synthesis of continuing professional development for opioid agonist therapy. International Journal of Drug Policy, 108, 103807. https://doi.org/https://doi.org/10.1016/j.drugpo.2022.103807
Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020). Pharmacological treatment of methamphetamine/amphetamine dependence: A systematic review. CNS Drugs, 34(4), 337‒365. https://doi.org/10.1007/s40263-020-00711-x
Smothers, Z., Reynolds, V., McEachern, M., Derouin, A. L., Carter, B. M., & Muzyk, A. (2018). Substance use education in schools of nursing: A Systematic Review of the Literature. Nurse Educato,r 43(3), 136‒139. https://doi.org/10.1097/nne.0000000000000449
Srivastava, P., & Hopwood, N. (2009). A practical Iterative framework for qualitative daata analysis. International Journal of Qualitative Methods, 8(1), 76‒84. https://doi.org/10.1177/160940690900800107
Strauss, A., & Corbin, J. (1998). Basics of qualitative research techniques. SAGE Publications, Inc.
Tait, R. J., Whetton, S., Shanahan, M., Cartwright, K., Ferrante, A., Gray, D., Kaye, S., McKetin, R., Pidd, K., Ritter, A., Roche, A., & Allsop, S. (2018). Quantifying the societal cost of methamphetamine use to Australia. International Journal of Drug Policy, 62, 30‒36. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.08.015
Thomas, K., & Muzyk, A. J. (2018). Surveys of substance use disorders education in US pharmacy programs. Mental Health Clinician, 8(1), 14‒17. https://doi.org/10.9740/mhc.2018.01.014
Tomko, J. R., & Giannetti, V. J. (2013). Knowledge, attitudes, and professional practices versus personal beliefs of pharmacists regarding chemically dependent patients. Mental Health Clinician, 3(6), 302‒308. https://doi.org/10.9740/mhc.n183649
UNODC. (2022). World drug report 2022. United Nations. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html
Uthurralt, N., Miao Cao, F., Reid, S. E., Nithyanandam, L., Burns, L., & Day, C. A. (2023). Characteristics of clients entering women-only substance use treatment services in New South Wales. Women's Health, 19, 17455057231200133. https://doi.org/10.1177/17455057231200133
Ward, B., Lane, R., Quinn, B., & Russell, G. (2021). Qualitative understandings of access to primary care services for consumers who use methamphetamine [Journal Article]. Australian Journal of General Practice, 50(7), 505‒510. https://search.informit.org/doi/10.3316/informit.064054487622009
Watson, T., & Hughes, C. (2012). Pharmacists and harm reduction: A review of current practices and attitudes. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 145(3), 124‒127. e122. https://doi.org/10.3821/145.3.cpj124
Wenthur, C. J., Cross, B. S., Vernon, V. P., Shelly, J. L., Harth, B. N., Lienhoop, A. D., Madison, N. R., & Murawski, M. M. (2013). Opinions and experiences of Indiana pharmacists and student pharmacists: The need for addiction and substance abuse education in the United States. Research in Social and Administrative Pharmacy, 9(1), 90‒100. https://doi.org/https://doi.org/10.1016/j.sapharm.2012.03.003
Williams, E. C., Achtmeyer, C. E., Young, J. P., Berger, D., Curran, G., Bradley, K. A., Richards, J., Siegel, M. B., Ludman, E. J., Lapham, G. T., Forehand, M., & Harris, A. H. S. (2018). Barriers to and facilitators of alcohol use disorder pharmacotherapy in primary care: A qualitative study in Five VA clinics. Journal of General Internal Medicine, 33(3), 258‒267. https://doi.org/10.1007/s11606-017-4202-z
